B7-H1 (PD-L1, CD274) suppresses host immunity in T-cell lymphoproliferative disorders

Схожие документы

• Monocytes promote tumor cell survival in T-cell lymphoproliferative disorders and are impaired in their ability to differentiate into mature dendritic cells
  по: Wilcox, Ryan A., et al.
  Опубликовано: (2009)
• Bim and PD-1 identify effector CD8 T cells responsive to anti-PD-1 therapy in metastatic melanoma patients
  по: Dronca, Roxana, et al.
  Опубликовано: (2015)
• A proliferation-inducing ligand mediates follicular lymphoma B-cell proliferation and cyclin D1 expression through phosphatidylinositol 3-kinase–regulated mammalian target of rapamycin activation
  по: Gupta, Mamta, et al.
  Опубликовано: (2009)
• Endogenous tumor-reactive CD8(+) T cells are differentiated effector cells expressing high levels of CD11a and PD-1 but are unable to control tumor growth
  по: Liu, Xin, et al.
  Опубликовано: (2013)
• Triggering interferon signaling in T cells with avadomide sensitizes CLL to anti-PD-L1/PD-1 immunotherapy
  по: Ioannou, Nikolaos, et al.
  Опубликовано: (2021)